ORELABRUTINIB, FLUDARABINE, CYCLOPHOSPHAMIDE, and OBINUTUZUMAB (OFCG) for FIRST-LINE TREATMENT of CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTICENTER, INVESTIGATOR-INITIATED STUDY (CWCLL-001 STUDY)

Category Primary study
Conference29th Congress of the European Hematology Association, EHA 2024
Year 2024
This article has no abstract
Epistemonikos ID: 4d8cef650827ab2a44aedb73eec2d06c5a6070df
First added on: Mar 07, 2026